Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Dalbeni

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|March 3, 2021
Treatments for NAFLD: State of ArtAlessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences|April 28, 2023
NAFLD/MAFLD: New EvidenceAlessandro Mantovani, Andrea Dalbeni
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2020
NAFLD, MAFLD and DAFLDAlessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences|March 10, 2022
Recent Developments in NAFLDAlessandro Mantovani, Andrea Dalbeni
Frontiers in Endocrinology|September 29, 2023
Editorial: The NAFLD-MAFLD conundrumAndrea Dalbeni, Rahul Kumar, Somaya Albhaisi
Hepatobiliary Surgery and Nutrition|March 14, 2022
Glucose-lowering agents and reduced risk of incident non-alcoholic fatty liver disease: new insightsAlessandro Mantovani, Rosa Lombardi, Andrea Dalbeni
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2020
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysisAlessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni
International Journal of Public Health|April 12, 2020
Coronavirus disease 2019 (COVID-19): we don't leave women aloneAlessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 18, 2014
Could vitamin D supplements be a new therapy for heart failure? Possible pathogenic mechanisms from data of intervention studiesAndrea Dalbeni, Pietro Delva, Pietro Minuz
Hepatology (Baltimore, Md.)|December 13, 2023
Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisAndrea Dalbeni, Alessandro Mantovani, Rosa Lombardi, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|March 3, 2021
Treatments for NAFLD: State of ArtAlessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences|April 28, 2023
NAFLD/MAFLD: New EvidenceAlessandro Mantovani, Andrea Dalbeni
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2020
NAFLD, MAFLD and DAFLDAlessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences|March 10, 2022
Recent Developments in NAFLDAlessandro Mantovani, Andrea Dalbeni
Frontiers in Endocrinology|September 29, 2023
Editorial: The NAFLD-MAFLD conundrumAndrea Dalbeni, Rahul Kumar, Somaya Albhaisi
Hepatobiliary Surgery and Nutrition|March 14, 2022
Glucose-lowering agents and reduced risk of incident non-alcoholic fatty liver disease: new insightsAlessandro Mantovani, Rosa Lombardi, Andrea Dalbeni
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2020
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysisAlessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni
International Journal of Public Health|April 12, 2020
Coronavirus disease 2019 (COVID-19): we don't leave women aloneAlessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 18, 2014
Could vitamin D supplements be a new therapy for heart failure? Possible pathogenic mechanisms from data of intervention studiesAndrea Dalbeni, Pietro Delva, Pietro Minuz
Hepatology (Baltimore, Md.)|December 13, 2023
Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisAndrea Dalbeni, Alessandro Mantovani, Rosa Lombardi, et al.
Pageof 10